Targeting arterial remodeling: a key tile in the mosaic of the therapeutic effects of relaxin in cardiovascular disease.
Bani
Daniele
D
D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D051381:Rats; D011918:Rats, Inbred SHR; D011994:Recombinant Proteins / Q000627:therapeutic use; D012065:Relaxin / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
D011994:Recombinant Proteins; D014665:Vasodilator Agents; D012065:Relaxin